We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Inflammation-Induced Mucosal KYNU Expression Identifies Human Ileal Crohn's Disease.
- Authors
Huhn, Meik; Herrero San Juan, Martina; Melcher, Balint; Dreis, Caroline; Schmidt, Katrin G.; Schwiebs, Anja; Collins, Janet; Pfeilschifter, Josef M.; Vieth, Michael; Stein, Jürgen; Radeke, Heinfried H.
- Abstract
The widely varying therapeutic response of patients with inflammatory bowel disease (IBD) continues to raise questions regarding the unclarified heterogeneity of pathological mechanisms promoting disease progression. While biomarkers for the differentiation of Crohn's disease (CD) versus ulcerative colitis (UC) have been suggested, specific markers for a CD subclassification in ileal CD versus colonic CD are still rare. Since an altered signature of the tryptophan metabolism is associated with chronic inflammatory disease, we sought to characterize potential biomarkers by focusing on the downstream enzymes and metabolites of kynurenine metabolism. Using immunohistochemical stainings, we analyzed and compared the mucosal tryptophan immune metabolism in bioptic samples from patients with active inflammation due to UC or CD versus healthy controls. Localization-specific quantification of immune cell infiltration, tryptophan-metabolizing enzyme expression and mucosal tryptophan downstream metabolite levels was performed. We found generally increased immune cell infiltrates in the tissue of all patients with IBD. However, in patients with CD, significant differences were found between regulatory T cell and neutrophil granulocyte infiltration in the ileum compared with the colon. Furthermore, we observed decreased kynurenine levels as well as strong kynureninase (KYNU) expression specifically in patients with ileal CD. Correspondingly, significantly elevated levels of the kynurenine metabolite 3-hydroxyanthranilic acid were detected in the ileal CD samples. Highlighting the heterogeneity of the different phenotypes of CD, we identified KYNU as a potential mucosal biomarker allowing the localization-specific differentiation of ileal CD versus colonic CD.
- Subjects
CROHN'S disease; TRYPTOPHAN; INFLAMMATORY bowel diseases; SUPPRESSOR cells; ULCERATIVE colitis; IMMUNOSTAINING
- Publication
Journal of Clinical Medicine, 2020, Vol 9, Issue 5, p1360
- ISSN
2077-0383
- Publication type
Article
- DOI
10.3390/jcm9051360